Corient Private Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Corient Private Wealth's AMGN Position: Q2 2026 in Review
Corient Private Wealth reduced its Amgen (AMGN) stake by 15% in Q2 2026, selling an estimated $28.8M and leaving 466,785 shares worth $169M. The position accounts for 0.23% of the portfolio, ranked #82.
Corient Private Wealth first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $190M in Q1 2026. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Corient Private Wealth held 466,785 shares of Amgen worth $169M as of Q2 2026.
- Corient Private Wealth sold 84,082 Amgen shares in Q2 2026, an estimated $28.8M.
- Amgen made up 0.23% of Corient Private Wealth's portfolio in Q2 2026, its #82 holding.
- Corient Private Wealth first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
- Corient Private Wealth's Amgen position peaked at $190M in Q1 2026.
- 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.